Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination Strategies
Matthew G. Cottingham(University of Oxford), Michael A. Skinner(Imperial College London), Angela T. Newton(PsiOxus Therapeutics (United Kingdom)), Richard J. Anderson(University of Maryland, Baltimore), M. Keith Howard(PsiOxus Therapeutics (United Kingdom)), Manola Zago(PsiOxus Therapeutics (United Kingdom)), Jörg Schneider(Johannes Gutenberg University Mainz), André van Maurik(PsiOxus Therapeutics (United Kingdom))
Cited by 18
Related Papers
A p16 <sup>INK4a</sup> -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
|Science|1995|1.1k
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
|PLoS ONE|2012|398
Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
|New England Journal of Medicine|2005|380